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ATRX is a centromeric heterochromatin binding protein belonging to the SNF2 family of helicase/ATPases with chromatin remodeling activity.
Mutations in the human ATRX gene result in X-linked a-thalassaemia with mental retardation (ATRX) syndrome and correlate with changes in
methylation of repetitive DNA sequences. We show here that ATRX also functions to regulate key stages of meiosis in mouse oocytes. At the
germinal vesicle (GV) stage, ATRX was found associated with the perinucleolar heterochromatin rim in transcriptionally quiescent oocytes.
Phosphorylation of ATRX during meiotic maturation is dependent upon calcium calmodulin kinase (CamKII) activity. Meiotic resumption also
coincides with deacetylation of histone H4 at lysine 5 (H4K5 Ac) while ATRX and histone H3 methylated on lysine 9 (H3K9) remained bound to
the centromeres and interstitial regions of condensing chromosomes, respectively. Inhibition of histone deacetylases (HDACs) with trichostatin A
(TSA) disrupted ATRX binding to the centromeres of hyperacetylated chromosomes resulting in abnormal chromosome alignments at metaphase
II (MII). Similarly, while selective ablation of ATRX by antibodymicroinjection and RNA interference (RNAi) had no effect on the progression of
meiosis, it had severe consequences for the alignment of chromosomes on the metaphase II spindle. These results suggest that genome-wide
epigenetic modifications such as global histone deacetylation are essential for the binding of ATRX to centromeric heterochromatin. Moreover,
centromeric ATRX is required for correct chromosome alignment and organization of a bipolar meiotic metaphase II spindle.
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The completion of meiosis in higher eukaryotes requires
the segregation of homologous chromosomes during the first
meiotic division, followed by subsequent segregation of
sister chromatids to opposing poles of the meiotic spindle
upon resumption of metaphase II. Although the mechanisms
involved in the establishment of a haploid chromosome
complement in mature gametes are not fully understood,
accurate reduction in chromosome number depends on the0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reseved.
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Kennett Square, PA 19348, USA.specialized and distinct functions of centromeres at the
metaphase I (MI) and metaphase II (MII) stages of meiosis
(Nasmyth, 2002; Petronczki et al., 2003). For example,
separation of homologous chromosomes at anaphase I occurs
while sister chromatid cohesion is maintained at centromeric
heterochromatin regions on the chromosomes (Bernard and
Allshire, 2002; Eijpe et al., 2003; Jibak Lee et al., 2003;
Petronczki et al., 2003). Centromeres are specialized hetero-
chromatin domains with unique properties to bind large
protein complexes that mediate attachment of chromosomes
to microtubules at the meiotic spindle (Pluta et al., 1995).
Importantly, alterations in chromosome segregation during
meiosis constitute a major cause of aneuploidy in mammalian
oocytes (Hassold and Hunt, 2001).
Centromeric heterochromatin regions in the eukaryotic
genome have been long recognized cytologically as highly
condensed, transcriptionally repressive domains present dur-
ing the interphase stage of the cell cycle (Dillon and Festen-
stein, 2002). However, the molecular composition and
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ning to be unraveled. Current evidence indicates that in
addition to repetitive centromeric DNA sequences, a higher
order chromatin structure provided by regularly spaced
nucleosomes (the basic unit of chromatin formation) is
essential for the binding of large protein complexes to
heterochromatin regions in the nucleus (Dillon and Festen-
stein, 2002; Jenuwein and Allis, 2001; Moazed, 2001).
Moreover, recent advances in our understanding of the role
of histone acetylation and histone methylation in modulating
higher order chromatin structure have contributed signifi-
cantly to the initial dissection of the molecular components
and mechanisms of heterochromatin formation in model
organisms such as fission yeast andDrosophila melanogaster
(Jenuwein and Allis, 2001; Moazed, 2001). Studies have
since revealed some evolutionary conservation in mammals
of the basic mechanisms of chromatin modifications in which
binding of different histone proteins to the chromatin tem-
plate, as well as their posttranslational modifications (i.e.,
histone acetylation and histone methylation), contributes to
the establishment of critical epigenetic marks. For instance,
methylation of histone H3 at lysine 9 (H3K9 methylation)
provides a binding site for heterochromatin binding protein
1 (HP1) in human and mouse fibroblasts in an essential
step for the nucleation of heterochromatin formation and
proper chromosome segregation (Bannister et al., 2001;
Lachner et al., 2001). Importantly, heterochromatin forma-
tion also occurs outside of centromeric regions (Dillon and
Festenstein, 2002), and both centromeric and pericentro-
meric heterochromatin formation is required for the mod-
ulation of homologous chromosome interactions during
male meiosis in mice (Peters et al., 2001) and for proper
chromosome segregation in yeast (Bernard and Allshire,
2002; Bernard et al., 2001).
In spite of its essential role for the progression of meiosis,
the mechanisms involved in centromeric and pericentromeric
heterochromatin formation in mouse oocytes are unknown.
More than 20 proteins have been shown to bind centromeric
heterochromatin (Saffery et al., 2000) in human somatic cells;
however, amongst these, one of the least understood groups is
that of the chromatin remodeling complexes. ATRX is a
member of the SWI/SNF family of helicases or ATPases with
chromatin remodeling activity (Gibbons et al., 1997; Picketts
et al., 1998). ATRX has been mapped to the long arm of the
human X chromosome (Xq13.3) and contains an open
reading frame encoding a 280 kDa protein with a plant
homeodomain (PHD) region at the amino terminus respon-
sible for interactions with HP1 and a helicase domain at the
carboxyl terminal region (Picketts et al., 1998). Spontaneous
mutations in the PHD region in humans induce a-thalassae-
mia, seizures, and in extreme cases, gonadal dysgenesis
(ATRX syndrome) (Gibbons et al., 1997). Moreover, ATRX
binds pericentric heterochromatin regions in mouse somatic
cell lines and to the short arms of human acrocentric chro-
mosomes (McDowell et al., 1999). The specific cellular
function of ATRX is not known at present; however, ATRXassociates with HP1a duringmitosis (Be´rube´ et al., 2000) and
with the SET domain of chromatin modifying proteins
(Cardoso et al., 1998).
The patterns of ATRX expression and nuclear compart-
mentalization in mammalian oocytes are not known. Impor-
tantly, whether ATRX has a function in germ cell nuclear
architecture and the progression of meiosis remains undeter-
mined. This study was undertaken (I) to determine the
mechanisms involved in regulating the binding of ATRX to
centromeric heterochromatin in mammalian oocytes and (II)
to test the hypothesis that the ATRX protein plays a role
during female meiosis. Our results indicate that genome-wide
epigenetic modifications such as global histone deacetylation
at the onset of meiosis are essential for the binding of ATRX
to centromeric heterochromatin in mouse chromosomes.
Moreover, centromeric ATRX is required for the maintenance
of a bipolar metaphase II spindle and for the establishment of
proper chromosome alignment during meiosis.Materials and methods
Oocyte collection and culture
Oocyte–cumulus cell complexes were obtained from 22-
day old (C57BL/6J  SJL/J) F1 mice that had been injected
48 h earlier with 5 IU pregnant mare serum gonadotropin
(PMSG; National Hormone and Peptide Program, NIDDK).
Oocytes were collected in 2.5 ml of TCM-199 medium
(GIBCO, Life Technologies, Grand Island, NY) supple-
mented with 10 Al of Milrinone (Sigma Co., St Louis,
MO) to prevent germinal vesicle (GV) breakdown. Cumulus
cells were removed by repeated pipetting. Denuded oocytes
were cultured in fresh TCM-199 supplemented with 10 AM
Milrinone (Sigma) at 37jC under an atmosphere of 5% O2,
5% CO2, and 90% N2 before their allocation to experimental
groups. Trichostatin A (TSA; Biomol Research Lab. Inc.,
Plymouth Meeting, PA), a potent and specific inhibitor of
histone deacetylases (HDACs) (Yoshida et al., 1995), was
used at a concentration of 100 nM. KN-93 (Biomol), a
specific inhibitor of calcium calmodulin kinase II (CamKII),
was used at a concentration of 10 AM.
Western blot analysis
Groups of 300 denuded oocytes were washed in phos-
phate-buffered saline (PBS) supplemented with protease
inhibitor cocktail (1 mM DTT, 1 mM pefabloc, 10 Ag/ml
leupeptin, aprotinin, and pepstatin; Sigma) and frozen at
70jC in 10 Al of Laemmli buffer (Laemmli, 1970). In
order to remove phosphate groups, 1 IU protein phosphatase
(PPA; Calbiochem, La Jolla, CA) was added to samples in
phosphatase buffer (50 mM Tris–HCl, 5 mM DTT, 20 mM
MgCl2, and 100 Ag/ml BSA). Samples of metaphase I or II
oocytes were incubated at 30jC for 30 min. This reaction
was subsequently terminated by the addition of an equal
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80jC. Samples were thawed on ice then heated to
100jC for 5 min. Proteins were separated by electrophoresis
in 10% polyacrylamide gels containing 0.1% SDS and
transferred onto a hydrophobic polyvinylidene difluoride
(PVDF) membrane (Amersham, Piscataway, NJ) for 1 h at
100 V. The membrane was blocked in PBT buffer (2% BSA
in PBS with 0.2% Tween 20; PBT) for 1 h at room
temperature, then incubated overnight with a goat anti-
ATRX antibody (1:1000; Santa Cruz Biotechnology) at
4jC. After several washes in PBT, the membrane was
exposed to a horseradish peroxidase-conjugated rabbit an-
ti-goat secondary antibody (Jackson Immuno research, West
Chester, PA) for 1 h at room temperature. ATRX protein was
visualized by a chemiluminescence reaction using the
ECL+Plus system (Amersham).
Immunochemistry
To determine the subcellular localization of ATRX pro-
tein, oocytes at the GV stage were fixed with 2% parafor-
maldehyde for 15 min at room temperature then permeated
with PBS supplemented with 0.2% Triton X for 10 min.
Oocytes were washed and stored at 4jC in PBS + 10% bovine
serum. To detect ATRX after germinal vesicle breakdown,
oocytes with condensing chromosomes were exposed to a
hypotonic treatment of 1% sodium citrate for 12 min. Protein
cross-linking was performed by incubation with 2% parafor-
maldehyde as described above. Oocytes were exposed to a
1:5 dilution of the 23c ATRX antibody, kindly provided by D.
Higgs (McDowell et al., 1999), for 1 h at room temperature;
after several washes in PBT buffer, oocytes were incubated
for 1 h in a 1:1000 dilution of a Cy3-conjugated sheep anti-
mouse IgG (Jackson Immuno research). Maturing oocytes
were simultaneously stained with antibodies directed against
either histone H4 acetylated on lysine 5 (H4K5 Ac; 1:400),
histone H3 methylated on lysine 9 (H3K9 Meth; Upstate
Biotechnology; 1:400), or histone H3 trimethylated on lysine
9 (H3K9Me3 1:5000; a generous gift from K. Muegge) and
detected with a 1:1000 dilution of an Alexa-Fluor 488 anti-
rabbit secondary antibody (Molecular Probes, Inc., Eugene,
OR). Centromeric proteins Cenp-A, B, and C were detected
with a 1:10000 dilution of the CREST antibody (kindly
provided by W. Earnshaw) followed by a 1:150 dilution of
an Alexa-Fluor 488 goat anti-human antibody (Molecular
Probes). DNAwas counterstained with Hoechst 33258 (Sig-
ma) and oocytes were mounted on Poly-Prepk slides (Sig-
ma). For analysis of the meiotic spindle, oocytes were fixed
overnight in 4% paraformaldehyde then incubated with 3.8
Ag/ml of a mouse monoclonal anti-h-tubulin (IgG; Sigma)
antibody for 1 h and detected with 1.3 Ag/ml of an FITC-
conjugated anti-mouse IgG (Jackson Immuno research).
Chromosomes were counterstained with 10 Ag/ml propidium
iodide (Sigma). Laser scanning confocal microscopy was
performed on a Leica TCS-NTconfocalmicroscope equipped
with an air-cooled argon ion laser (568 nm excitation) system(Leica Microsystems, Exton, PA). Epifluorescence analysis
was conducted using an ultraviolet light (340–380 nm
excitation) and a rhodamine (515–560 nm) filter on a
DMRX/E microscope (Leica Microsystems).
Antibody microinjection
Denuded oocytes were cultured under oil in 50 Al of TCM-
199 medium supplemented with 10 AMMilrinone (Sigma) to
maintain arrest at the GV stage. A mixture of the anti-ATRX
antibodies 23c, 39f (McDowell et al., 1999), and a polyclonal
antibody directed against the C-terminus of ATRX (Santa
Cruz Biotech.) was microinjected into the cytoplasm of
denuded oocytes. The polyclonal anti-ATRX antibody was
injected at a final concentration of 0.2 Ag/Al. The 23c and 39f
antibodies were provided as tissue culture supernatants and
co-injected as an equal volume (1:1:1) mixture or after a 1:2
dilution in TCM-199 medium. Control oocytes were micro-
injected with 1 Ag/Al IgG1 (Sigma). Microinjected oocytes
were then cultured in 500 Al of TCM-199 medium supple-
mented with 10 AM Milrinone for 24 h. Oocytes were
released from prophase arrest after extensive rinsing in
TCM-199 medium and allowed to resume meiosis following
transfer to fresh TCM-199 medium for a period of 14 h. For
the analysis of meiotic configurations, microinjected oocytes
were fixed overnight in 4% paraformaldehyde before immu-
nostaining of the meiotic spindle.
RNA interference after microinjection of double stranded or
short interfering RNA
To determine the function of ATRX during meiosis,
translation of the ATRX protein in mouse oocytes was
specifically inhibited using an RNA interference (RNAi)
approach. Double stranded (DS) RNAs were generated by
modifications of previously described methods (Svoboda et
al., 2000; Wianny and Zernicka-Goetz, 1999). Sense and
antisense sequences were transcribed in vitro from PCR
products with the use of an in vitro ligated T7 RNA
polymerase (Ambion Inc., Austin, TX). Primers were
designed from a region of the plant homeodomain (PHD)
of the mouse ATRX sequence and used as a template to
generate double stranded RNAs. Equimolar quantities of
sense and antisense RNAwere annealed in vitro and exposed
to RNAse A (Ambion) to remove single stranded RNA then
subjected to phenol–chloroform extraction. Formation of
double stranded RNAwas confirmed by gel electrophoresis.
Short interfering (esi) RNAs were generated by enzymatic
cleavage of DS RNAwith RNA polymerase III (Yang et al.,
2002). Double stranded RNAs and esi RNAs were also
generated from a completely unrelated sequence (Cyclo-
philin) to be used as the negative control.
Preovulatory oocytes were maintained at the GV stage by
exposure to the phosphodiesterase inhibitor Milrinone (10
AM) and microinjected in the cytoplasm with a solution
containing 0.2 Ag/Al of a double stranded (DS) RNA or a
Fig. 2. Association of ATRX with nucleolar heterochromatin and
persistence of histone H4 acetylation in the germinal vesicle (GV) of
preovulatory oocytes. Epifluorescence microscopy of representative GV
stage mouse oocytes presenting the non-surrounded nucleolar (NSN)
configuration (A–C) or the surrounded nucleolar (SN) configuration
(D–F). Oocytes were simultaneously stained with Hoechst 33258 (blue;
A, D), with an antibody that specifically recognizes histone H4
acetylated at lysine 5 (H4K5 Ac; green, B, E) and with a mouse
monoclonal antibody against ATRX (red; C, F). Heterochromatin regions
in the oocyte genome showing bright Hoechst fluorescence and ATRX
staining are indicated (arrowheads). The position of the nucleolus is
indicated by (*).
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released from prophase arrest 24 h after microinjection and
allowed to undergo meiotic maturation in vitro for 14 h.
To confirm that microinjection of (DS) RNA specifically
ablated ATRX protein without inducing nonspecific effects
on the expression of other chromatin binding proteins, micro-
injected oocytes were simultaneously labeled with a mouse
monoclonal antibody against ATRX and with a polyclonal
antibody against histone H3 methylated at lysine 9 (H3K9).
Control mock-injected oocytes were microinjected with cul-
ture medium alone (no RNAi). Furthermore, a nonrelated DS
RNA generated against Cyclophilin (0.2Ag/Al) was injected
into a different group of oocytes to further validate the
specificity of the RNAi approach.
Statistical analysis
Data are presented as the mean percentage of at least three
independent experiments; variation among replicates is pre-
sented as the standard error of the mean (SEM). The percent-
age of oocytes exhibiting acetylated histones (H4K5 Ac),
methylated histones (H3K9 meth), or ATRX staining, as well
as the proportion of oocytes undergoing meiotic maturation
after antibody microinjection or RNAi, were analyzed using
arcsine transformed data and compared by analysis of vari-
ance (ANOVA) using StatView (StatView: SAS Institute Inc.,
Cary, NC). When a significant F-ratio was defined by
ANOVA, groups were compared using the Fisher’s PLSD
post-hoc test. Differences were considered significant when
(P < 0.05).Results
ATRX is localized at heterochromatin domains in the
mammalian oocyte genome
ATRX binds centromeric heterochromatin regions in
human and mouse somatic cells (McDowell et al., 1999).Fig. 1. Subnuclear localization of ATRX to heterochromatin domains in
mouse oocytes. Fluorescent micrograph of mouse oocytes after staining
with the DNA-specific fluorochrome Hoechst 33258 (blue; A). Immuno-
chemical localization of the ATRX protein (red) revealed that ATRX
preferentially localizes with sites of bright Hoechst fluorescence (B; arrow).
Simultaneous labeling of centromeric proteins with the CREST antibody
(green) confirmed that ATRX binds to centromeric heterochromatin
domains in the oocyte genome (C; arrow). The position of the nucleolus
is indicated by (*).However, whether ATRX associates with heterochromatin
domains in mammalian oocytes is not known. Experi-
ments were thus conducted to determine the subnuclear
localization of ATRX in fully grown mouse oocytes.
Immunocytochemical studies revealed that the ATRX
protein (red) is preferentially associated with sites of
bright Hoechst fluorescence (blue) in the oocyte genome
(Figs. 1A, B; arrows). Importantly, simultaneous immu-
nostaining of the centromeric proteins Cenp-A, B, and C
(green) with the CREST antibody (Pluta et al., 1995)
confirmed that ATRX binds centromeric heterochromatin
domains in the germinal vesicle (Figs. 1B, C; arrows),
although some faint ATRX staining could still be
detected in the nucleoplasm. These results indicate that
ATRX is a component of centromeric heterochromatin
domains in the germinal vesicle.
The mouse oocyte genome undergoes dynamic mod-
ifications in chromatin structure. For example, growing
oocytes exhibit a decondensed chromatin configuration
termed non-surrounded nucleolus (NSN). In contrast,
chromatin is found condensed in close apposition with
the nucleolus in a configuration termed surrounded
nucleolus (SN) in transcriptionally quiescent, preovulato-
ry oocytes (BouniolBaly et al., 1999; De La Fuente and
Eppig, 2001; Debey et al., 1993; Mattson and Albertini,
1990; Wickramasinghe and Albertini, 1992). Importantly,
in somatic cells, histone acetylation is associated with the
maintenance of a decondensed, transcriptionally permis-
sive chromatin structure (Grunstein, 1997; Turner, 2000).
However, whether changes in histone acetylation occur
during the transition into the SN configuration in mouse
oocytes is not clear. Acetylation of histone H4 at lysine
Fig. 3. Chromosomal localization of ATRX and global histone deacetyla-
tion associated with meiotic resumption. The patterns of acetylated histone
H4 (H4K5 Ac) and ATRX localization were determined in preovulatory
oocytes at the GV stage (0 h) or after meiotic maturation at times indicated
(A). The proportion of oocytes presenting H4K5 Ac staining is dramatically
reduced ( P < 0.0001) upon resumption of meiosis (2 h). Chromosomes
were stained with Hoechst 33258 (B). Histone H4K5 Ac is no longer
associated with condensing chromosomes at later stages of meiosis and is
only detected as diffuse cytoplasmic staining (green; C). In contrast, ATRX
remains associated with chromosomes throughout meiosis (red; D). No
changes were detected in the electrophoretic mobility of ATRX protein
during the first 6 h of meiotic maturation (E). Data are presented as the
mean F SEM of four independent experiments.
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status of histone H4 (Kruhlak et al., 2001); thus, experi-
ments were conducted to determine whether changes in
H4K5 Ac staining occur in transcriptionally repressed
oocytes showing the SN configuration. In oocytes pre-
senting the NSN configuration, heterochromatin regions
exhibit a characteristic bright staining pattern after expo-
sure to the DNA fluorochrome Hoechst 33258 (Blue;
Fig. 2A, arrowhead). Immunochemical detection of his-
tone H4 acetylated at lysine 5 (H4K5 Ac) revealed high
levels of histone acetylation (green) in the nucleoplasm
of NSN oocytes except for heterochromatin regions, in
which the H4K5 Ac signal was considerably reduced
(Fig. 2B, arrowhead). This antibody exclusively detects
histone H4 acetylated on lysine 5 and shows no cross-
reactivity with deacetylated histone H4 (data not shown).
In contrast, ATRX was found predominantly associated
with heterochromatin regions corresponding to bright
Hoechst staining foci (Fig. 2C, arrowhead), although
faint nucleoplasmic staining could also be detected. In
oocytes presenting the SN configuration, chromatin is
condensed and distributed around the nucleolus (Fig. 2D)
including the small nucleoli observed in a small percent-
age of oocytes (lower arrowhead). In spite of this
chromatin condensation, histone H4 remained fully acet-
ylated as indicated by the presence of H4K5 Ac staining
in oocytes with the SN configuration (Fig. 2E). More-
over, ATRX was found in close apposition with the
perinucleolar region in oocytes with the SN configuration
(Fig. 2F, arrowheads).
Chromosomal ATRX localization and global histone
deacetylation upon meiotic resumption
The patterns of histone H4 acetylation (H4K5 Ac) and
ATRX staining were then analyzed simultaneously in
groups of oocytes up to 6 h after the onset of meiosis
in vitro. The proportions of oocytes presenting H4K5 Ac
and/or ATRX staining at different time points evaluated
are illustrated in Fig. 3A; the values represent results of
three independent experimental replicates. Consistent with
our previous experiment, the majority of preovulatory
oocytes (97.5%) at the GV stage (0 h; n = 165) present
a high level of acetylated histone H4 (H4K5 Ac) in the
nucleoplasm as well as ATRX staining (100%) in associ-
ation with heterochromatin domains (Fig. 3A). Interest-
ingly, coincident with the resumption of meiosis (2 h; n =
147), a wave of global histone deacetylation takes place
in the oocyte genome, and H4K5 Ac staining is no longer
detectable on condensing chromosomes. Instead, only
diffuse staining is observed in the cytoplasm of maturing
oocytes (Figs. 3B, C). This was reflected in a significant
(P < 0.0001) decrease in the proportion of oocytes
(6.2%) presenting H4K5 Ac staining associated with
chromosomes (Fig. 3A). In contrast, ATRX remained
associated with chromosomes in a punctuate patternresembling staining of centromeric heterochromatin (Fig.
3D). This pattern was consistently observed at 2 h (78%),
4 h (95.7%; n = 131), and 6 h (95.4%; n = 158) after
meiotic resumption. Western blot analysis of the ATRX
protein over a similar period of meiotic maturation
revealed a single band of the expected molecular weight
(280 kDa) in oocytes at the GV stage (0 h) and after the
onset of meiosis (2–6 h). No differences were observed
in the relative levels or the electrophoretic mobility of
ATRX protein (Fig. 3E) or in the levels of H4K5 Ac at
these time points (data not shown). These results suggest
that global histone deacetylation occurs in the chromo-
somes of mouse oocytes upon meiotic resumption. In
addition, ATRX remains associated with focal sites on
condensing chromosomes even at a time when major
chromatin modifications are taking place during meiosis.
In order to determine whether ATRX binds to centro-
meric heterochromatin throughout meiosis, oocytes at the
germinal vesicle stage and at metaphase I (10 h after the
onset of meiosis) were immunostained with a monoclonal
antibody against ATRX as described above; in this
experiment, however, oocytes were simultaneously labeled
with a monoclonal antibody against histone H3 methyl-
ated at lysine 9 (H3K9). Consistent with our previous
Fig. 5. Phosphorylation of ATRX protein during meiosis is mediated by the
calcium calmodulin kinase (CamKII) pathway. Western blot analysis of
ATRX protein in oocytes at the germinal vesicle (GV) stage, at metaphase I
(MI) 10 h after in vitro maturation, or at the metaphase II (MII) stage after
14 h of meiotic maturation. ATRX is detected as a single band of 280 kDa
at the GV stage; however, a doublet with slower mobility is detected in
oocytes at MI and MII stage (A). Treatment of oocyte protein extracts with
protein phosphatase (MII PPA) increased the mobility of ATRX to that
observed at the GV stage (A). Treatment of oocytes with the calcium
calmodulin kinase II (CamKII) inhibitor KN-93 (10 AM) during the
progression of meiosis prevented phosphorylation of ATRX protein in
oocytes at the MI (Lane 3) and MII (Lane 4) stage (B). This experiment was
repeated three times with identical results and a representative example is
shown.
Fig. 4. ATRX binds to centromeric heterochromatin during meiosis. Laser
scanning confocalmicroscopy of preovulatory oocytes at the GV stage (A, B)
and metaphase I of meiosis (C). Single scan of a GV stage oocyte presenting
diffuse nucleoplasmic staining of histone H3 methylated at lysine 9 (H3K9)
as detected with a linear antibody shown in green, localization of ATRX
protein is shown in red (A). Serial reconstruction on the Z axis for the same
oocyte (B). H3K9 methylation persists on the interstitial regions of
condensing chromosomes throughout meiosis, whereas ATRX is localized
exclusively with centromeric heterochromatin regions (C). Immunostaining
with the trimethylated H3K9Me3 antibody (green) specifically detects
heterochromatin domains in the GV (D; arrow). ATRX (red) is preferentially
co-localized with centromeric heterochromatin (E; arrow) and exclusively
co-localized with the centromeres of condensed chromosomes (F; arrow),
whereas H3K9Me3 staining (green) spreads throughout condensed chromo-
somes. The nucleolus is indicated by (*).
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ATRX staining at heterochromatin regions in oocytes at
the GV stage (Figs. 4A, B; shown in red). Histone H3K9
methylation (Figs. 4A, B; shown in green) was detected
in a diffuse pattern throughout the nucleoplasm of GV
stage oocytes including those regions stained with ATRX.
However, in contrast with the histone deacetylation event
observed in chromosomes upon meiotic resumption, his-
tone H3K9 methylation was consistently detected at
interstitial regions of condensed chromosomes throughout
meiosis (Fig. 4C; green). Interestingly, ATRX staining
was consistently found exclusively associated with cen-
tromeric heterochromatin regions in meiotic chromosomes
(Fig. 4C; red).
Use of a trimethylated antibody against H3K9Me3 that
exclusively stains centromeric heterochromatin (Peters et
al., 2001) revealed several centromeric heterochromatin
domains in the germinal vesicle (Fig. 4D; green) and
confirmed that ATRX (red) preferentially co-localized
with centromeric heterochromatin domains (Fig. 4E; ar-
row). Interestingly, upon chromosome condensation,
H3K9Me3 methylation is redistributed throughout the en-
tire length of the chromosomes, whereas ATRX was
observed exclusively localized to the centromeres of
meiotic chromosomes (Fig. 4F; arrow). ATRX was also
found to co-localize with centromeric proteins in con-
densed chromosomes after immunostaining with the
CREST antibody (data not shown).Calcium calmodulin kinase II-dependent phosphorylation of
ATRX in MI and MII stage oocytes
Western blot analysis with the ATRX antibody against
the C-terminus of the protein revealed a single band of
280 kDa in oocytes at the GV stage. However, analysis
of maturing oocytes revealed a slower migrating band
that consistently appeared as a doublet in oocytes at the
metaphase I (MI; 10 h) and metaphase II (MII; 14 h)
stages (Fig. 5A). To determine whether the slow migrat-
ing forms result from a phosphorylation event, taking
place during meiosis, protein extracts obtained from MII
stage oocytes were treated with a protein phosphatase
(PPA) to remove phosphate groups that might be present.
Similar results were obtained for three independent ex-
perimental replicates, and a representative example is
shown in Fig. 5A. Treatment of oocyte extracts with
PPA increased the mobility of ATRX protein detected in
MII stage oocytes, demonstrating that the slow migrating
doublet is due to phosphorylation of the ATRX protein at
metaphase II (Fig. 5A; MII PPA). However, a doublet
rather than single band was consistently detected even
after PPA treatment. Similar results were obtained with
oocytes at the MI stage (data not shown). Previous
studies of Drosophila chromosomes indicate that phos-
phorylation of the heterochromatin binding protein (HP1)
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Fig. 6. Inhibition of histone deacetylation at the onset of meiosis disrupts
the binding of ATRX to centromeric heterochromatin (A). Proportion of
metaphase II oocytes showing histone H4 lysine 5 acetylation (H4K5 Ac;
green) and localization of ATRX to centromeric heterochromatin (red)
under different experimental conditions. Control metaphase II oocytes show
deacetylated chromosomes (B, C) and binding of ATRX to centromeric
heterochromatin (D). Inhibition of histone deacetylases with trichostatin A
(TSA) induced chromosome hyperacetylation (E–F) and significantly
reduced ( P < 0.0001) the binding of ATRX to centromeric domains (G).
Metaphase II stage oocytes with hyperacetylated chromosomes present
abnormal chromosome alignments to the meiotic spindle (H–J). Oocytes
were exposed to TSA (100 nM) at the GV stage (TSA 8 h), during meiotic
maturation (TSA M), or at the GV stage and during meiotic progression
(TSA 8 h + M). Data are presented as the meanF SEM of four independent
experiments.
R. De La Fuente et al. / Developmental Biology 272 (2004) 1–14 7is under control of the casein kinase pathway (Zhao and
Eissenberg, 1999). However, treatment of maturing
oocytes with the casein kinase inhibitor 5,6-dichloro-1-
h-D-ribofuranosylbenzimidazole (DRB) had no effect on
the phosphorylation of ATRX during meiosis (data not
shown). To determine whether ATRX phosphorylation is
under the control of an alternative signaling pathway,
oocytes were treated with KN-93, a specific inhibitor of
the calcium calmodulin kinase II (CamKII) pathway.
Treatment of mouse oocytes with KN-93 interferes with
meiotic resumption (Su and Eppig, 2002); therefore, in
the present study, denuded oocytes were cultured for 2
h and allowed to undergo germinal vesicle breakdown
before exposure to 10 AM KN-93 for 10 h. No changes
in the electrophoretic mobility of ATRX occur immedi-
ately after germinal vesicle breakdown (Fig. 3E), thus
ensuring that oocytes were exposed to KN-93 after
germinal vesicle breakdown but before ATRX phosphor-
ylation. Consistent with previous experiments, control,
nontreated oocytes at the GV stage or the metaphase
(MII) stage yielded a single fast migrating band or a
slow migrating doublet form of ATRX, respectively (Fig.
5B). However, exposure of maturing oocytes to the
calcium calmodulin kinase II (CamKII) inhibitor KN-93
prevented phosphorylation of ATRX at both MI and MII
stages (Fig. 5B).
Global histone deacetylation at the onset of meiosis is
required for continuous binding of ATRX to centromeric
heterochromatin
To determine whether the wave of histone deacetylation
observed upon meiotic resumption is of functional signif-
icance for the association of ATRX with centromeric
domains, oocytes were allowed to undergo meiotic matu-
ration in the presence or absence of trichostatin A (TSA), a
potent inhibitor of histone deacetylases (HDACs). Denud-
ed oocytes at the GV stage (n = 126) were treated with
TSA (100 nM) for 8 h (TSA 8 h), rinsed in fresh media,
and then allowed to undergo meiotic maturation in vitro
for 14 h. Oocytes were also exposed to TSA for 8 h at the
GV stage and during meiotic maturation (TSA 8 h + M;
n = 184) or during the maturation period exclusively (TSA
M; n = 169). Control oocytes (n = 147) were cultured in
the presence of 0.01% dimethyl sulfoxide (DMSO), which
was used as a vehicle to dissolve TSA. The proportions of
maturing oocytes presenting acetylated histone H4 (H4K5
Ac) and ATRX staining at centromeric heterochromatin in
three experimental replicates are illustrated in Fig. 6A.
Consistent with our previous experiments, histone H4
acetylation (H4K5 Ac) was absent from the chromosomes
of control MII oocytes, and only cytoplasmic staining was
observed (Fig. 6C; green). At this stage, ATRX was
consistently found associated with centromeric heterochro-
matin foci in 99.3% of the oocytes (Fig. 6D; red). Faint
chromosomal H4K5 Ac was detected in only 23% ofcontrol oocytes at the MII stage (Fig. 6A). Importantly,
inhibition of HDACs with TSA during meiotic progression
induced a state of hyperacetylation in condensed MI stage
chromosomes as determined by intense H4K5 Ac staining
(Figs. 6E, F; green) in 100% of oocytes (P < 0.0001).
Moreover, ATRX was no longer found associated with
centromeric heterochromatin domains in meiotic chromo-
somes. ATRX was found associated with centromeric
heterochromatin in only 24% of oocytes treated at the
GV stage (TSA 8 h), in 25% of oocytes treated during
meiotic maturation exclusively (TSA M), and in 9.3% of
oocytes treated with TSA both at the GV stage and during
Fig. 7. Microinjection of ATRX antibodies disrupts chromosome alignment
at the metaphase II stage. Proportion of oocytes at different stages of
meiosis after microinjection of an equal volume (1:1:1) mixture of
antibodies (23c, 39f, and polyclonal anti-ATRX) against different amino
termini of the ATRX protein or after injection of a 1:2 dilution of mixed
antibodies. Control oocytes were injected with nonimmune IgG (A). The
majority of control noninjected oocytes or oocytes microinjected with a
nonimmune IgG exhibited a barrel-shaped bipolar spindle (green) with
chromosomes (red) tightly aligned at the equatorial region (C). Microin-
jection of ATRX antibodies increased the proportion ( P < 0.0001) of
oocytes presenting improper chromosome alignment on the metaphase II
spindle (B). Although the spindle in the middle panel (D) corresponds to a
metaphase II oocyte, it is no longer bipolar and chromosomes are only
loosely attached peripherally to the microtubular network (the polar body in
this oocyte was out of the focal plane). Chromosomes were also found
misaligned within the spindle microtubules (E).
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(P < 0.0001) compared with that in control oocytes (Fig.
6G). Similar effects were observed in the majority of MII
stage oocytes, in which some hyperacetylated chromo-
somes were consistently found completely separated from
the metaphase plate (Figs. 6H, I) and with no ATRX
staining at centromeric heterochromatin (Fig. 6J). These
results suggest that epigenetic modifications, such as
global histone deacetylation, during meiosis are essential
to maintain the association of heterochromatin binding
proteins such as ATRX with centromeric domains in the
chromosome.
Microinjection of ATRX antibodies disrupts chromosome
alignment at MII
To gain some insight into the possible function of
ATRX during meiotic progression in mouse oocytes, a
mixture of antibodies directed against different regions of
the ATRX protein were microinjected into the cytoplasm
of GV stage oocytes. Groups of oocytes were micro-
injected with a 1:1:1 (n = 119) or 1:2; 1:2; 1:2 (n = 78)
mixture of the 23c, 39f, and the anti-ATRX, C-terminus
domain antibodies or with an equivalent volume of a
nonimmune IgG1 (n = 98) as a negative control. Fur-
thermore, an additional group of uninjected control
oocytes (n = 96) was also included. Following microin-
jection, oocytes were maintained arrested at the GV stage
for 24 h and subsequently allowed to resume meiosis.
The proportion of oocytes that reached different stages of
meiosis in four independent experimental replicates is
illustrated in Fig. 7A. No differences were observed in
the proportion of oocytes that reached the MII stage (84–
92%) after microinjection with ATRX antibodies or IgG
(92.1%) compared to uninjected control oocytes (93.4%).
However, analysis of meiotic spindle configurations at the
MII stage revealed a significant increase (P < 0.0001) in
the proportion of oocytes with abnormal chromosome
alignments on the meiotic spindle after injection of a
(1:2; 42.1%) or a (1:1; 47.2%) mixture of ATRX anti-
bodies compared with control IgG (10.5%) or noninjected
oocytes (4.2%) (Fig. 7B). Control and IgG injected
oocytes presented a typical barrel-shaped bipolar MII
spindle with chromosomes tightly aligned at the equatorial
region (Fig. 7C). In contrast, microinjection of ATRX
antibodies resulted in abnormal meiotic configurations in
which the MII spindle was no longer bipolar and
appeared as a rosette-like configuration with chromo-
somes loosely attached at peripheral regions of the
microtubular network (Fig. 7D). Furthermore, additional
configurations were commonly observed in which chro-
mosomes were found loosely attached to a disorganized
meiotic spindle (Fig. 7E). These results indicate that
microinjection of ATRX antibodies has no effect on the
progression of maturing oocytes to the MII stage. How-
ever, meiotic spindle organization is severely compro-mised after immunoneutralization of ATRX as indicated
by a significant increase in the proportion of oocytes with
misaligned chromosomes.
Specific ablation of ATRX with RNAi disrupts chromosome
alignment to the MII spindle
To further test the hypothesis that ATRX plays a role
during meiosis, the mRNA transcript encoding the ATRX
protein in mouse oocytes was specifically ablated using an
RNA interference (RNAi) approach. Oocytes were micro-
injected in the cytoplasm with double stranded (DS) RNA or
a short interfering (esi) double stranded RNA. Oocytes were
released from prophase arrest 24 h after microinjection and
allowed to undergo meiotic maturation in vitro. The pro-
portion of oocytes with centromeric ATRX staining and
Fig. 8. Selective ablation of ATRX by RNA interference (RNAi).
Proportion of metaphase II oocytes presenting histone H3 lysine 9
methylation (H3K9) and localization of ATRX to centromeric heterochro-
matin (A). Control patterns are shown for the chromosomes (B, blue),
H3K9 (C, green), and ATRX (D, red). Microinjection of double stranded
(DS ATRX) and short interfering (esi ATRX), specifically abrogated ATRX
staining without affecting H3K9 methylation in condensed chromosomes
(E–G) and (H–J), respectively. No significant effects were observed with
control nonrelated (Cyclophilin) double stranded (DS) RNAs (K–M) or
with esi RNAs against Cyclophilin (N–P). Oocytes were microinjected at
the GV stage and allowed to undergo meiotic maturation for a period of 14
h. Data are presented as the meanF SEM of four independent experiments.
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independent experimental replicates is illustrated in (Fig.
8A). Consistent with our previous experiments, >90% of
control MII stage oocytes (n = 67) exhibit H3K9 staining
(Fig. 8C) at condensed chromosomes and focal sites of
ATRX labeling at centromeric heterochromatin regions (Fig.
8D). Microinjection of double stranded RNA (n = 69)
generated from the ATRX sequence (DS ATRX) had no
effect on the proportion of oocytes stained with H3K9 (Fig.
8A). Moreover, the levels of H3K9 staining in this group
were similar to those observed in control oocytes micro-
injected with medium alone (Fig. 8F). In stark contrast,
microinjection of DS ATRX significantly reduced the pro-
portion (P < 0.0001) of oocytes with ATRX labeling, and
showed only minimal cytoplasmic background fluorescence
(Fig. 8G). Similarly, microinjection with short interfering,
double stranded RNA (esi) from the ATRX sequence (n =Fig. 9. Selective ablation of ATRX by RNA interference (RNAi) disrupts
proper chromosome alignment in metaphase II stage mouse oocytes (A).
Proportion of microinjected oocytes at the germinal vesicle (GV),
metaphase I (MI), or metaphase II (MII) stage after 14 h of in vitro
maturation. Inhibition of ATRX by double stranded (DS ATRX) and short
interfering (esi ATRX) had no effect on the progression of meiosis.
However, microinjection of DS ATRX or esi ATRX significantly increased
( P < 0.05) the proportion of oocytes with abnormal chromosome
alignments on the metaphase II spindle (B–E). Control oocyte shown in
(C). Chromosomes were counterstained with propidium iodide and are
shown in red; microtubules were stained with anti h-tubulin and are shown
in green. Data are presented as the mean F SEM of four independent
experiments.
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H3K9 staining in condensed chromosomes (Fig. 8I), where-
as staining for ATRX was abrogated in the majority (>80%)
of microinjected oocytes (Fig. 8J). Microinjection of a
completely unrelated double stranded RNA sequence (DS
Cyclo; n = 57) had no effect on H3K9 staining (Fig. 8L),
and no effects on ATRX protein expression were detected
(Fig. 8M). Similarly, microinjection of a 30 nucleotide short
interfering (esi) RNA (esi Cyclo; n = 51) had no effect on
the ATRX protein as demonstrated by simultaneous detec-
tion of H3K9 methylation (Fig. 8O) and focal sites of ATRX
staining in centromeric heterochromatin (Fig. 8P). These
results indicate that RNAi is an effective strategy for the
selective ablation of ATRX.
To determine the potential function of ATRX during
meiotic progression, preovulatory oocytes were microin-
jected with double stranded RNA (DS ATRX) or short
interfering RNA (esi ATRX) at the GV stage and allowed
to resume meiosis in vitro as above. The proportions of
oocytes reaching different stages of meiosis in three inde-
pendent experimental replicates under various treatment
conditions are shown in (Fig. 9A). No significant differ-
ences were observed in the proportion of oocytes (83–90%)
that reached the MII stage compared with uninjected control
(88%) oocytes. However, analysis of chromosome and
spindle configurations revealed a significant increase (P =
0.003) in the proportion of MII oocytes with abnormal
chromosome alignments on the meiotic spindle (Fig. 9B).
Control oocytes microinjected with maturation medium
alone (n = 60) exhibited a typical barrel-shaped meiotic
spindle with chromosomes tightly aligned at the equatorial
region (Fig. 9C). In contrast, a high proportion of oocytes
(55%; n = 59) microinjected with DS ATRX (Fig. 9D) or esi
ATRX (55.3%, n = 77) presented aberrant chromosome
configurations with improper alignment on spindle micro-
tubules (Fig. 9E). These results suggest that centromeric
ATRX is essential for proper chromosome alignment on the
MII spindle.Discussion
Accurate segregation of homologous chromosomes and
of sister chromatids during mammalian meiosis is crucial for
the subsequent transmission of a euploid chromosome
complement to the developing conceptus (Hassold and
Hunt, 2001). Chromosome segregation depends on the
establishment of physical and biochemical interactions be-
tween spindle microtubules and specialized chromosomal
regions localized at centromeric heterochromatin (Dobie et
al., 1999; Karpen and Allshire, 1997; Pluta et al., 1995;
Sullivan, 2001). In this study, we provide evidence indicat-
ing that ATRX, a member of the SNF2 family of helicase/
ATPases with chromatin remodeling activity, is present at
heterochromatin regions of the mouse oocyte genome.
Results indicate that global or genome-wide histone deace-tylation occurs upon meiotic resumption in mouse oocytes
and that global histone deacetylation is necessary to main-
tain the association of the ATRX protein to centromeric
heterochromatin domains in condensed chromosomes. In
contrast with the highly dynamic changes in histone acety-
lation taking place upon germinal vesicle breakdown, the
levels of histone H3 methylated at lysine 9 (H3K9)
remained constant in the maternal genome during meiosis.
Moreover, Western blot analysis revealed that ATRX is
phosphorylated after 10–14 h of in vitro maturation coin-
cident with oocytes reaching the MI and MII stage, respec-
tively. Pharmacological inhibition of the calcium calmodulin
kinase (CamKII) pathway with KN-93 prevented the ap-
pearance of the slow migrating forms of ATRX indicating
that this phosphorylation event is mediated by the CamKII
pathway in mouse oocytes. Importantly, functional ablation
of ATRX protein by antibody microinjection and RNAi
indicates that ATRX plays an essential role in the organi-
zation of proper chromosome alignment on the meiotic MII
spindle.
Global histone deacetylation during meiosis is essential for
binding of ATRX to centromeric heterochromatin domains
Localization of ATRX to centromeric heterochromatin
has been previously demonstrated in human and mouse
somatic cell lines (McDowell et al., 1999). However, the
role of ATRX in nuclear compartmentalization and hetero-
chromatin formation during meiosis is not known. The
mammalian genome is subject to a series of dramatic
changes in chromatin structure and function during game-
togenesis (Debey et al., 1993; Mattson and Albertini, 1990;
Patterton and Wolffe, 1996; Sassone-Corsi, 2002; Wickra-
masinghe and Albertini, 1992). Although the mechanisms
involved in such dynamic chromatin modifications are not
fully understood, analysis of component molecules of chro-
matin remodeling complexes, such as ATRX, in mouse
oocytes provides a unique model to determine the contri-
bution of heterochromatin binding proteins to germ cell
nuclear architecture. Immunochemical analysis of growing
oocytes at the GV stage revealed that ATRX is co-localized
predominantly with centromeric proteins detected by the
CREST antibody and with focal sites of bright Hoechst
fluorescence known to correspond to heterochromatin
regions (Peters et al., 2001; Pluta et al., 1995). However,
diffuse ATRX staining could also be detected, albeit at
lower levels, in the nucleoplasm of oocytes with decon-
densed chromatin presenting the non-surrounded nucleolus
(NSN) configuration. Moreover, analysis of preovulatory
oocytes with the surrounded nucleolus (SN) configuration,
in which chromatin is condensed, indicate that ATRX is
localized in close apposition to the perinucleolar hetero-
chromatin rim. These findings are consistent with a pre-
dominant association of ATRX with heterochromatin
domains during prophase I of meiosis. The molecular
composition and mechanisms leading to the formation of
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with the SN configuration are not clear. However, our
results indicate that ATRX is present, along with additional
nucleolar components such as the upstream binding factor
(UBF), RNA polymerase I subunits, and the splicing factor
B23 (Zatsepina et al., 2000), in the perinucleolar hetero-
chromatin rim of preovulatory mouse oocytes. Interestingly,
a direct interaction between ATRX and UBF has also been
demonstrated in human metaphase chromosomes wherein
ATRX has been recently shown to associate with the short
arms of acrocentric chromosomes carrying ribosomal DNA
sequences (Gibbons et al., 2000).
Laser scanning confocal microscopy revealed that acet-
ylated histone H4 was found in a diffuse nucleoplasmic
staining pattern irrespective of oocyte chromatin configura-
tion, except for heterochromatin regions, where its expres-
sion was only faintly detected. These observations are
consistent with the net deacetylated status of heterochroma-
tin domains in cells at the G2 stage of the cell cycle
(Grunstein, 1997; Taddei et al., 1999). Interestingly, upon
germinal vesicle breakdown, a wave of global histone
deacetylation takes place at which time ATRX is bound
exclusively to the centromeric heterochromatin regions of
condensing chromosomes. Histone acetylation is generally
associated with decondensed, transcriptionally competent
chromatin regions, whereas histone deacetylation is largely
associated with condensed chromatin. However, until now,
most studies on histone deacetylation have been based on
the analysis of promoter regions or alternative regulatory
sequences of single copy genes (Grunstein, 1997; Turner,
2000). Our results indicate that global or genome-wide
histone modifications are also of significant functional
relevance during meiosis. Consistent with this hypothesis,
recent studies indicate that chromatin modifications in yeast
occur not only at specific promoter regions or at regulatory
elements of single copy genes, but also throughout large
sections of the genome (Berger and Felsenfeld, 2001;
Katan-Khaykovich and Struhl, 2002; Vogelauer et al.,
2000). Moreover, global deacetylation of histone H3 at
lysines 9 and 14 during mitosis and lysine 12 of histone
H4 in mouse oocytes has also been described recently (Kim
et al., 2003; Kruhlak et al., 2001). Our results extend these
observations and demonstrate that global histone deacetyla-
tion at the onset of meiosis is of functional significance for
the binding of ATRX to centromeric heterochromatin.
The mechanisms regulating the specific localization of
ATRX to centromeric domains are not clear. However, it has
been suggested that histone modifications taking place on a
genome-wide scale are important to reduce the nonspecific
binding of heterochromatin proteins to chromosomal regions
other than centromeric heterochromatin (van Leeuwen and
Gottschling, 2002). In this study, induction of histone hyper-
acetylation with TSA did not prevent meiotic chromosome
condensation. However, the presence of hyperacetylated
histones in chromosomes interfered with the specific locali-
zation of ATRX to centromeric heterochromatin resulting inabnormal chromosome attachments with the meiotic spindle.
Long-term exposure (> 5 days) of human fibroblasts (Taddei
et al., 2001) or yeast cells (Ekwall et al., 1997; Grewal et al.,
1998) to TSA also disrupts the binding of the different
subunits of heterochromatin binding protein 1 (HP1) (Taddei
et al., 2001) or the transcriptional co-repressor KRAB-asso-
ciated-protein 1 (KAP-1) to centromeres of mitotic chromo-
somes (Matsuda et al., 2001). Collectively, these results
suggest that epigenetic modifications such as global histone
deacetylation may be essential during the progression of both
mitosis and meiosis for the specific recruitment of hetero-
chromatin proteins to centromeric domains in condensed
chromosomes. Furthermore, our studies indicate that meiosis
is particularly susceptible to disruptions in histone deacety-
lation as exposure to TSA for only 8 h was sufficient to
prevent binding of ATRX to heterochromatin domains in
mouse oocytes.
The CamKII pathway mediates phosphorylation of the
ATRX protein during meiosis
The serine residues of ATRX are subject to phosphory-
lation in human mitotic cells (Be´rube´ et al., 2000). However,
whether ATRX is subject to posttranslational modifications
during meiosis has not been determined previously. More-
over, the cell signaling pathway(s) involved in ATRX
phosphorylation are not known. Analysis of posttranslation-
al modifications and subcellular localization of ATRX
during meiotic progression revealed that ATRX is exclu-
sively bound to the centromeres of condensing chromo-
somes shortly after germinal vesicle breakdown. However,
the phosphorylated forms of ATRX cannot be detected until
10–14 h of meiotic maturation, in oocytes at the MI and
MII stages, respectively. These results indicate that in
contrast with other chromatin binding proteins, such as the
human homologue of Drosophila suppression of position
effect variegation SUV39H1 and HP1, whose centromeric
heterochromatin localization is dependent upon protein
phosphorylation (Aagaard et al., 2000; Zhao and Eissen-
berg, 1999), the binding of ATRX to centromeric domains
precedes and therefore is not dependent on its phosphory-
lation in mouse oocytes. Our results also contrast with
studies of ATRX in human somatic cell lines in which
localization of ATRX to condensed chromatin during mito-
sis has been suggested to be phosphorylation-dependent
(Be´rube´ et al., 2000). Species-specific differences in hetero-
chromatin protein content and organization may account for
this discrepancy. For example, comparison of HP1 protein
content and posttranslational modifications in HeLa cells
and mouse 3T3 fibroblasts revealed that different isoforms
of HP1 segregate to different nuclear compartments and
exhibit different patterns of cell cycle-related phosphoryla-
tion in these two cell lines (Minc et al., 1999).
The nature of the two ATRX isoforms that appear in MI
and MII of meiosis is not known. It is conceivable that these
two ATRX isoforms correspond to phosphorylation at two
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alternatively spliced transcript in mouse oocytes. Experi-
ments are in progress to distinguish between these possibil-
ities. Inhibition of the calcium calmodulin kinase (CamKII)
pathway by KN-93 prevented the phosphorylation of ATRX
at both MI and MII. These results provide, for the first time,
biochemical evidence indicating that phosphorylation of the
ATRX protein is under the control of the CamKII pathway
during mammalian meiosis. This is in contrast with HP1
phosphorylation, which in Drosophila cells is under the
control of the casein kinase pathway (Zhao and Eissenberg,
1999). These results suggest that phosphorylation of differ-
ent heterochromatin binding proteins is under the control of
distinct cell signaling pathways that may be of relevance for
the spatiotemporal regulation of centromere and spindle
microtubule interactions.
Binding of ATRX to centromeric heterochromatin is
important for the alignment of chromosomes to the meiotic
MII spindle
Localization of ATRX to centromeric domains during
meiosis suggested a possible functional role in chromosome
architecture and/or segregation. Functional ablation of
ATRX by RNAi and antibody microinjection during meiotic
progression produced similar results. Abrogation of ATRX
function had no effect on the progression of maturing
oocytes to the MII stage. However, meiotic spindle organi-
zation was severely compromised as indicated by a signif-
icant increase in the proportion of oocytes exhibiting
chromosomes with abnormal alignment on the spindle
microtubules. The most common configuration observed
presented groups of chromosomes establishing a loose
attachment to peripheral regions of the meiotic MII spindle.
However, in extreme cases, spindle bipolarity was com-
pletely lost and chromosomes were arranged in a rosette-like
configuration resembling a prometaphase stage, although
such oocytes always exhibited a set of homologous chro-
mosomes extruded into the polar body. Although these
studies do not rule out the possibility that chromosome
misalignment in response to ATRX ablation also occurs at
MI, the high proportion of oocytes reaching MII after ATRX
depletion argues against this possibility and suggests that
the function of ATRX in mediating chromosome alignment
is predominantly at the MII stage in mouse oocytes. Cohe-
sion between sister chromatids at pericentromeric hetero-
chromatin regions is crucial for chromosome alignment on
the MII spindle (Bernard et al., 2001; Nasmyth, 2002;
Petronczki et al., 2003; Tanaka et al., 2000). It is thus
possible that interference with ATRX function decreases the
efficiency of centromeric heterochromatin in mediating
proper chromosome alignment exclusively at the metaphase
II stage. In support of this hypothesis, Nonaka et al. (2002)
recently demonstrated that cohesin complexes are enriched
at centromeric heterochromatin of sister chromatids by a
direct physical association with the heterochromatin proteinSwi6 and its mouse homologue, HP1. This establishes a
direct interaction among centromeric heterochromatin pro-
tein composition, centromere cohesion, and chromosome
segregation (Bernard et al., 2001; Nonaka et al., 2002). Our
results provide the first evidence indicating that in addition
to its role as a putative transcriptional regulator (Gibbons et
al., 1997, 2000; McDowell et al., 1999), ATRX also
functions during key stages of meiosis in mouse oocytes.
Our experiments have also revealed that different post-
translational modifications occur on the core histones H3
and H4 during meiotic progression. For example, in contrast
with the rapid histone deacetylation event observed upon
germinal vesicle breakdown, histone methylation persists
through global changes in chromatin modifications during
meiosis. These results are consistent with a role of histone
methylation in providing the chromosomal environment
necessary for the recruitment of heterochromatin binding
proteins such as HP1 to centromeric domains (Bannister et
al., 2001; Dillon and Festenstein, 2002; Lachner et al., 2001;
Rea et al., 2000). Analysis of protein–protein interactions
by yeast-two hybrid and co-immunoprecipitation studies
indicates that ATRX physically interacts with HP1 in
somatic cells (Be´rube´ et al., 2000; Le Douarin et al.,
1996). It is thus conceivable that functional ablation of
ATRX disrupts higher order structure at centromeric hetero-
chromatin or alternative aspects of chromosome architecture
that are essential for the establishment of a functional
centromere. In support of this hypothesis, additional studies
suggest that HP1 is involved in mediating chromosome–
microtubule interactions (Ainsztein et al., 1998), as func-
tional ablation of HP1 in Drosophila embryos disrupts
heterochromatin condensation resulting in abnormal chro-
mosome segregation (Kellum and Alberts, 1995).
Centromeric domains exhibit unique properties to nucle-
ate kinetochore-associated proteins andmediate the poleward
segregation of chromosomes (Sullivan, 2001). Although
most studies have focused on the analysis of kinetochore-
binding proteins, a growing body of evidence suggests that
pericentric heterochromatin is also essential to maintain
centromere structure and function (Bernard et al., 2001;
Dobie et al., 1999; Jibak Lee et al., 2003; Melcher et al.,
2000; Peters et al., 2001). Importantly, the large protein
complexes present at centromeric domains are also subject
to epigenetic modification (Ekwall et al., 1997; Grewal et al.,
1998; Henikoff et al., 2001; Wiens and Sorger, 1998). Our
results indicate that global or genome-wide histone deacety-
lation is essential for the binding of ATRX to centromeric
domains during mammalian meiosis and provides functional
evidence indicating that ATRX, a centromeric heterochro-
matin protein, regulates key stages of meiosis in that it plays
an important role in establishing proper chromosome align-
ment and a bipolar meiotic spindle at metaphase II in mouse
oocytes. Epigenetic modifications such as histone deacetyla-
tion during meiosis may thus be essential for recruitment of
heterochromatin binding proteins involved in centromere
structure and function.
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